Drugmaker Merck & Co. said that a European drug agency has endorsed its hepatitis C treatment Victrelis, also known as boceprevir - a key step toward possible approval in the European Union.
The Food and Drug Administration said it approved a new HIV drug from Johnson & Johnson for patients who have not been treated with other medications for the virus.
Pearl Therapeutics Inc. presented efficacy and safety results in the company's Phase 2b study of PT003 (GFF MDI) in patients with moderate-to-very severe COPD at the annual meeting of the American Thoracic Society (ATS).
An independent safety review committee reported study findings on nearly 190,000 females who received at least one dose of Merck’s Gardasil, a quadrivalent human papillomavirus vaccine (qHPV) at two managed care associations between August 2006 and March 2008.
David M. Kendall, MD, currently chief scientific and medical officer of the American Diabetes Association, has been named distinguished medical fellow for Lilly.
SciFluor Life Sciences has secured $5 million in first-round funding from Allied Minds for a technology that enables late-stage fluorination of pharmaceutical drug candidates and other commercial chemicals.
While physicians routinely prescribe statin therapy combined with ezetimibe for some patients with high cholesterol., a study by University of Virginia Health System researchers adds to mounting evidence that ezetimibe may not stop significant artery wall thickening, or atherosclerosis, in some patients.
Penn State University scientists have assembled entire chromosomes from their component parts in a test tube, an achievement that reveals the process a cell uses to package the basic building blocks of an organism's genome.
WASHINGTON (AP) - A Food and Drug Administration advisory panel recommended on May 19, 2011 that a blockbuster drug from Abbott Laboratories still be marketed for use with other widely used cholesterol-lowering drugs, despite a government study that questioned the benefit.
ROCKVILLE, Md. (AP) - Biotech drugmaker, Human Genome Sciences Inc., said on May 20, 2011 a European committee has endorsed its lupus treatment Benlysta, a key step toward possible approval in the European Union.
Researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.
Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues.
ImageIQ, an imaging contract research organization specializing in advanced medical image acquisition, analysis, and visualization, announced the company’s spin-out of technology and expertise developed at Cleveland Clinic Innovations.
TTP LabTech announce that they are founding sponsors of the inaugural European Lab Automation conference and exhibition, to be held at the Conference Center Hamburg, Hamburg, Germany, from the June 30 - July 1.
Affymetrix, Inc. launched the Axiom myDesign Targeted Genotyping Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.